RNPEPL1
gene geneOn this page
Summary
RNPEPL1 (arginyl aminopeptidase like 1, HGNC:10079) is a protein-coding gene on chromosome 2q37.3, encoding Aminopeptidase RNPEPL1 (Q9HAU8). Broad specificity aminopeptidase which preferentially hydrolyzes an N-terminal methionine, citrulline or glutamine.
Enables metalloaminopeptidase activity. Involved in proteolysis.
Source: NCBI Gene 57140 — RefSeq curated summary.
At a glance
- GWAS associations: 18
- Clinical variants (ClinVar): 98 total
- Druggable target: yes
- MANE Select transcript:
NM_018226
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:10079 |
| Approved symbol | RNPEPL1 |
| Name | arginyl aminopeptidase like 1 |
| Location | 2q37.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000142327 |
| Ensembl biotype | protein_coding |
| OMIM | 605287 |
| Entrez | 57140 |
Gene structure
Transcript identifiers
Ensembl transcripts: 19 — 12 protein_coding, 6 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000270357, ENST00000437406, ENST00000451363, ENST00000460884, ENST00000464550, ENST00000471657, ENST00000481757, ENST00000486058, ENST00000493398, ENST00000498042, ENST00000885945, ENST00000885946, ENST00000885947, ENST00000885948, ENST00000885949, ENST00000920409, ENST00000920410, ENST00000971322, ENST00000971323
RefSeq mRNA: 1 — MANE Select: NM_018226
NM_018226
Canonical transcript exons
ENST00000270357 — 11 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000953532 | 240574113 | 240574348 |
| ENSE00000953533 | 240574515 | 240574628 |
| ENSE00001038855 | 240573775 | 240573891 |
| ENSE00001260222 | 240568484 | 240569114 |
| ENSE00001872415 | 240577599 | 240581372 |
| ENSE00003582098 | 240575502 | 240575610 |
| ENSE00003587572 | 240575030 | 240575142 |
| ENSE00003600009 | 240573110 | 240573261 |
| ENSE00003608709 | 240576535 | 240576765 |
| ENSE00003619356 | 240576848 | 240576990 |
| ENSE00003807076 | 240572423 | 240572563 |
Expression profiles
Bgee: expression breadth ubiquitous, 256 present calls, max score 98.50.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 33.6177 / max 918.7648, expressed in 1812 samples.
FANTOM5 promoters (8 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 26426 | 23.8480 | 1806 |
| 26430 | 3.2041 | 1481 |
| 26427 | 2.9176 | 1156 |
| 26428 | 1.1355 | 470 |
| 26431 | 1.1115 | 683 |
| 26425 | 0.7462 | 484 |
| 26429 | 0.5959 | 306 |
| 26423 | 0.0590 | 24 |
Top tissues by expression
276 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| apex of heart | UBERON:0002098 | 98.50 | gold quality |
| granulocyte | CL:0000094 | 98.15 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 96.98 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 96.84 | gold quality |
| mucosa of stomach | UBERON:0001199 | 95.83 | gold quality |
| body of stomach | UBERON:0001161 | 95.67 | gold quality |
| body of pancreas | UBERON:0001150 | 95.62 | gold quality |
| heart left ventricle | UBERON:0002084 | 95.24 | gold quality |
| gastrocnemius | UBERON:0001388 | 95.13 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 95.01 | gold quality |
| transverse colon | UBERON:0001157 | 94.92 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 94.92 | gold quality |
| type B pancreatic cell | CL:0000169 | 94.79 | silver quality |
| cardiac ventricle | UBERON:0002082 | 94.78 | gold quality |
| lower esophagus | UBERON:0013473 | 94.59 | gold quality |
| spleen | UBERON:0002106 | 94.58 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 94.58 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 94.47 | gold quality |
| right coronary artery | UBERON:0001625 | 94.38 | gold quality |
| olfactory bulb | UBERON:0002264 | 94.23 | gold quality |
| leukocyte | CL:0000738 | 94.15 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 94.14 | gold quality |
| right lung | UBERON:0002167 | 94.13 | gold quality |
| esophagus | UBERON:0001043 | 94.02 | gold quality |
| blood | UBERON:0000178 | 93.97 | gold quality |
| left coronary artery | UBERON:0001626 | 93.97 | gold quality |
| esophagus mucosa | UBERON:0002469 | 93.96 | gold quality |
| metanephros cortex | UBERON:0010533 | 93.88 | gold quality |
| monocyte | CL:0000576 | 93.84 | gold quality |
| mononuclear cell | CL:0000842 | 93.81 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 7.20 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
49 targeting RNPEPL1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-3910 | 99.95 | 71.13 | 2227 |
| HSA-MIR-124-3P | 99.89 | 73.74 | 3043 |
| HSA-MIR-506-3P | 99.89 | 73.55 | 3057 |
| HSA-MIR-4697-3P | 99.89 | 67.09 | 1123 |
| HSA-MIR-6780A-5P | 99.88 | 66.69 | 2776 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-6764-5P | 99.75 | 67.89 | 2304 |
| HSA-MIR-4524A-3P | 99.72 | 66.85 | 2406 |
| HSA-MIR-6752-3P | 99.72 | 66.71 | 1587 |
| HSA-MIR-149-3P | 99.72 | 68.22 | 3963 |
| HSA-MIR-3714 | 99.71 | 70.74 | 2671 |
| HSA-MIR-6883-5P | 99.69 | 68.05 | 3785 |
| HSA-MIR-6132 | 99.60 | 65.83 | 1554 |
| HSA-MIR-6836-5P | 99.60 | 65.62 | 1538 |
| HSA-MIR-1915-3P | 99.58 | 66.79 | 1988 |
| HSA-MIR-17-3P | 99.55 | 66.77 | 1311 |
| HSA-MIR-650 | 99.45 | 65.77 | 1309 |
| HSA-MIR-3612 | 99.45 | 66.02 | 1333 |
| HSA-MIR-5582-5P | 99.27 | 71.42 | 1879 |
| HSA-MIR-6852-5P | 99.17 | 66.69 | 2073 |
| HSA-MIR-6791-5P | 99.16 | 65.92 | 1844 |
| HSA-MIR-4292 | 99.16 | 65.57 | 1767 |
| HSA-MIR-6799-5P | 99.14 | 65.72 | 2093 |
| HSA-MIR-661 | 99.09 | 65.94 | 2062 |
| HSA-MIR-4695-5P | 99.06 | 64.87 | 1151 |
| HSA-MIR-6506-5P | 99.04 | 65.66 | 1386 |
| HSA-MIR-7113-3P | 98.75 | 65.71 | 1120 |
| HSA-MIR-423-5P | 98.69 | 67.48 | 1522 |
Literature-anchored findings (GeneRIF, showing 2)
- RT-PCR analysis of RNPEPL1 expression revealed a ubiquitous tissue distribution, consistent with a general housekeeping function, but also revealed alternative splicing of the mRNA in all tissues examined. (PMID:19508204)
- Characterization of the enzymatic properties of human RNPEPL1/aminopeptidase Z. (PMID:36545750)
Cross-species orthologs
17 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | rnpepl1 | ENSDARG00000007813 |
| mus_musculus | Rnpepl1 | ENSMUSG00000026269 |
| rattus_norvegicus | Rnpepl1 | ENSRNOG00000045775 |
| drosophila_melanogaster | CG7653 | FBGN0028935 |
| drosophila_melanogaster | CG9806 | FBGN0030222 |
| drosophila_melanogaster | CG2111 | FBGN0030223 |
| drosophila_melanogaster | CG6071 | FBGN0036186 |
| drosophila_melanogaster | CG5849 | FBGN0038897 |
| drosophila_melanogaster | CG3502 | FBGN0046253 |
| drosophila_melanogaster | CG31233 | FBGN0051233 |
| drosophila_melanogaster | CG31343 | FBGN0051343 |
| drosophila_melanogaster | CG31445 | FBGN0051445 |
| drosophila_melanogaster | SP1029 | FBGN0263236 |
| drosophila_melanogaster | CG46339 | FBGN0285963 |
| caenorhabditis_elegans | F49B2.6 | WBGENE00009865 |
| caenorhabditis_elegans | WBGENE00011587 | |
| caenorhabditis_elegans | WBGENE00012776 |
Paralogs (11): TRHDE (ENSG00000072657), LTA4H (ENSG00000111144), LNPEP (ENSG00000113441), ENPEP (ENSG00000138792), NPEPPS (ENSG00000141279), AOPEP (ENSG00000148120), ERAP1 (ENSG00000164307), ERAP2 (ENSG00000164308), ANPEP (ENSG00000166825), LVRN (ENSG00000172901), RNPEP (ENSG00000176393)
Protein
Protein identifiers
Aminopeptidase RNPEPL1 — Q9HAU8 (reviewed: Q9HAU8)
Alternative names: Arginyl aminopeptidase-like 1, Methionyl aminopeptidase
All UniProt accessions (3): Q9HAU8, C9JSI2, H7C200
UniProt curated annotations — full annotation on UniProt →
Function. Broad specificity aminopeptidase which preferentially hydrolyzes an N-terminal methionine, citrulline or glutamine.
Tissue specificity. Ubiquitously expressed. Expressed at relatively higher levels in heart and skeletal muscle.
Activity regulation. Inhibited by calcium but not affected by chloride ions. Inhibited by amastatin and to a lower extent by bestatin. Weakly inhibited by puromycin.
Cofactor. Binds 1 zinc ion per subunit.
Similarity. Belongs to the peptidase M1 family.
RefSeq proteins (1): NP_060696* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001930 | Peptidase_M1 | Family |
| IPR014782 | Peptidase_M1_dom | Domain |
| IPR015211 | Peptidase_M1_C | Domain |
| IPR016024 | ARM-type_fold | Homologous_superfamily |
| IPR027268 | Peptidase_M4/M1_CTD_sf | Homologous_superfamily |
| IPR034015 | M1_LTA4H | Family |
| IPR038502 | M1_LTA-4_hydro/amino_C_sf | Homologous_superfamily |
| IPR042097 | Aminopeptidase_N-like_N_sf | Homologous_superfamily |
| IPR045357 | Aminopeptidase_N-like_N | Domain |
| IPR049980 | LTA4H_cat | Domain |
Pfam: PF01433, PF09127, PF17900
UniProt features (11 total): binding site 4, chain 1, region of interest 1, sequence conflict 1, compositionally biased region 1, active site 1, site 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9HAU8-F1 | 87.45 | 0.75 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (2): 354 (proton acceptor); 442 (transition state stabilizer)
Ligand- & substrate-binding residues (4): 326–330; 353; 357; 376
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 97 (showing top):
BENPORATH_ES_WITH_H3K27ME3, CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN, GOMF_METALLOPEPTIDASE_ACTIVITY, BLALOCK_ALZHEIMERS_DISEASE_UP, CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN, GOBP_PROTEOLYSIS, GOMF_METALLOEXOPEPTIDASE_ACTIVITY, GOMF_PEPTIDASE_ACTIVITY, GOMF_AMINOPEPTIDASE_ACTIVITY, GOMF_EXOPEPTIDASE_ACTIVITY, GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_UP, GOMF_METALLOAMINOPEPTIDASE_ACTIVITY, LI_INDUCED_T_TO_NATURAL_KILLER_DN, DCA_UP.V1_DN, FOXN3_TARGET_GENES
GO Biological Process (1): proteolysis (GO:0006508)
GO Molecular Function (8): initiator methionyl aminopeptidase activity (GO:0004239), zinc ion binding (GO:0008270), metalloaminopeptidase activity (GO:0070006), aminopeptidase activity (GO:0004177), peptidase activity (GO:0008233), metallopeptidase activity (GO:0008237), hydrolase activity (GO:0016787), metal ion binding (GO:0046872)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| aminopeptidase activity | 2 |
| protein metabolic process | 1 |
| transition metal ion binding | 1 |
| metalloexopeptidase activity | 1 |
| exopeptidase activity | 1 |
| hydrolase activity | 1 |
| catalytic activity, acting on a protein | 1 |
| peptidase activity | 1 |
| catalytic activity | 1 |
| cation binding | 1 |
Protein interactions and networks
STRING
1208 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RNPEPL1 | CAPN10 | Q9HC96 | 889 |
| RNPEPL1 | GPR35 | Q9HC97 | 537 |
| RNPEPL1 | FAM98C | Q17RN3 | 493 |
| RNPEPL1 | JPT2 | Q9H910 | 452 |
| RNPEPL1 | ZNF688 | P0C7X2 | 396 |
| RNPEPL1 | ANKMY1 | Q9P2S6 | 395 |
| RNPEPL1 | RTP5 | Q14D33 | 393 |
| RNPEPL1 | MAB21L4 | Q08AI8 | 370 |
| RNPEPL1 | OR7A5 | Q15622 | 352 |
| RNPEPL1 | ALDH18A1 | P54886 | 350 |
| RNPEPL1 | ZNF785 | A8K8V0 | 348 |
| RNPEPL1 | FAM133B | Q5BKY9 | 347 |
| RNPEPL1 | THAP4 | Q8WY91 | 346 |
| RNPEPL1 | RNF150 | Q9ULK6 | 333 |
| RNPEPL1 | EML3 | Q32P44 | 330 |
IntAct
11 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| DKK4 | LRP5 | psi-mi:“MI:0914”(association) | 0.530 |
| RNPEPL1 | USP11 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| RNPEPL1 | VDAC1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| XAGE3 | PSMG1 | psi-mi:“MI:0914”(association) | 0.350 |
| RIN3 | psi-mi:“MI:0914”(association) | 0.350 | |
| TMCC3 | HSBP1 | psi-mi:“MI:0914”(association) | 0.350 |
| dinB | RNPEPL1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (11): RNPEPL1 (Affinity Capture-MS), RNPEPL1 (Affinity Capture-MS), RNPEPL1 (Affinity Capture-RNA), RNPEPL1 (Proximity Label-MS), RNPEPL1 (Affinity Capture-MS), RNPEPL1 (Affinity Capture-MS), RNPEPL1 (Affinity Capture-MS), RNPEPL1 (Affinity Capture-MS), RNPEPL1 (Affinity Capture-MS), RNPEPL1 (Affinity Capture-RNA), RNPEPL1 (Affinity Capture-RNA)
ESM2 similar proteins: A1A4I4, A5PKD8, A6NED2, A8MQ27, O35465, O60294, O75808, O94819, O95382, P70268, Q0MW30, Q14318, Q16512, Q2T9J0, Q32NY4, Q32P44, Q3B7U9, Q3MHW0, Q3U5Q7, Q3USL1, Q4R828, Q561R2, Q5EBM0, Q5EBP3, Q5PQP9, Q60806, Q63433, Q6PAT0, Q7T0L4, Q8BNW9, Q8BTU7, Q8BYR1, Q8IYL2, Q8N5A5, Q8NEP7, Q8VC03, Q8VHS5, Q8WXI3, Q91ZT7, Q96C12
Diamond homologs: A1CSI2, A1DG68, A2QKF8, A3LQI7, A3LRX6, A4QUC1, A5DGF3, A5DME6, A5DSS4, A6QPT7, A6RCT2, A6SAG8, A6ZS33, A7EJL9, A7THG7, G5E872, G5EFT4, O09175, O94544, P09960, P19602, P24527, P30349, P52922, Q0CFY9, Q0U653, Q10736, Q10740, Q1DVD1, Q2GY21, Q2TZ99, Q3SZH7, Q4X265, Q59NB8, Q5B0W8, Q6BW21, Q6C3E5, Q6CLD3, Q6FTM0, Q6IP81
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
98 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 78 |
| Likely benign | 2 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2074 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:240569112:GCC:G | donor_gain | 1.0000 |
| 2:240569115:G:GG | donor_gain | 1.0000 |
| 2:240572417:CCACA:C | acceptor_loss | 1.0000 |
| 2:240572418:CACAG:C | acceptor_loss | 1.0000 |
| 2:240572419:ACAGA:A | acceptor_loss | 1.0000 |
| 2:240572420:CAGAT:C | acceptor_loss | 1.0000 |
| 2:240572421:A:AC | acceptor_loss | 1.0000 |
| 2:240572421:A:AG | acceptor_gain | 1.0000 |
| 2:240572422:G:GA | acceptor_gain | 1.0000 |
| 2:240572422:GATCT:G | acceptor_gain | 1.0000 |
| 2:240572536:G:GT | donor_gain | 1.0000 |
| 2:240572559:TCAAG:T | donor_loss | 1.0000 |
| 2:240572560:CAAG:C | donor_loss | 1.0000 |
| 2:240572561:AAGG:A | donor_loss | 1.0000 |
| 2:240572562:AGG:A | donor_loss | 1.0000 |
| 2:240572563:GGTC:G | donor_loss | 1.0000 |
| 2:240572564:GTCAG:G | donor_loss | 1.0000 |
| 2:240572600:G:GT | donor_gain | 1.0000 |
| 2:240573258:CCAGG:C | donor_loss | 1.0000 |
| 2:240573259:CAGGT:C | donor_loss | 1.0000 |
| 2:240573261:GGTA:G | donor_loss | 1.0000 |
| 2:240573262:G:GA | donor_loss | 1.0000 |
| 2:240573262:G:GG | donor_gain | 1.0000 |
| 2:240573263:T:G | donor_loss | 1.0000 |
| 2:240574107:GTGCA:G | acceptor_loss | 1.0000 |
| 2:240574108:TGCA:T | acceptor_loss | 1.0000 |
| 2:240574109:GCA:G | acceptor_loss | 1.0000 |
| 2:240574110:CA:C | acceptor_loss | 1.0000 |
| 2:240574112:G:A | acceptor_loss | 1.0000 |
| 2:240574112:GGTAC:G | acceptor_gain | 1.0000 |
AlphaMissense
4674 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:240572501:C:A | R203S | 1.000 |
| 2:240572523:A:T | D210V | 1.000 |
| 2:240572559:T:A | V222D | 1.000 |
| 2:240574160:A:T | E329V | 1.000 |
| 2:240574231:C:G | H353D | 1.000 |
| 2:240574265:T:A | V364D | 1.000 |
| 2:240574279:T:A | W369R | 1.000 |
| 2:240574279:T:C | W369R | 1.000 |
| 2:240574281:G:C | W369C | 1.000 |
| 2:240574281:G:T | W369C | 1.000 |
| 2:240574291:T:A | W373R | 1.000 |
| 2:240574291:T:C | W373R | 1.000 |
| 2:240574301:A:T | E376V | 1.000 |
| 2:240574302:G:C | E376D | 1.000 |
| 2:240574302:G:T | E376D | 1.000 |
| 2:240574303:G:C | G377R | 1.000 |
| 2:240575074:G:C | G445R | 1.000 |
| 2:240576552:T:A | W510R | 1.000 |
| 2:240576552:T:C | W510R | 1.000 |
| 2:240569091:T:G | Y169D | 0.999 |
| 2:240572429:T:A | W179R | 0.999 |
| 2:240572429:T:C | W179R | 0.999 |
| 2:240572431:G:C | W179C | 0.999 |
| 2:240572431:G:T | W179C | 0.999 |
| 2:240572472:T:A | V193D | 0.999 |
| 2:240572500:C:A | N202K | 0.999 |
| 2:240572500:C:G | N202K | 0.999 |
| 2:240572501:C:G | R203G | 0.999 |
| 2:240572511:T:C | F206S | 0.999 |
| 2:240572514:C:A | P207Q | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000027805 (2:240569934 G>A), RS1000261543 (2:240569776 T>A), RS1000463206 (2:240570239 C>A,T), RS1000653815 (2:240572885 A>C,G), RS1000684795 (2:240572759 A>G), RS1000811184 (2:240578008 C>A,T), RS1000856300 (2:240572931 C>T), RS1000873743 (2:240578896 C>G,T), RS1001069092 (2:240568036 C>T), RS1001158624 (2:240577149 C>T), RS1001437120 (2:240567800 C>T), RS1001534339 (2:240568743 G>A,C,T), RS1001570608 (2:240580837 A>G), RS1001601880 (2:240581056 G>C), RS1001758353 (2:240575775 A>G)
Disease associations
OMIM: gene MIM:605287 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
18 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004599_289 | Mean platelet volume | 5.000000e-230 |
| GCST004603_219 | Platelet count | 1.000000e-34 |
| GCST004616_137 | Platelet distribution width | 3.000000e-44 |
| GCST004630_111 | Mean corpuscular hemoglobin | 3.000000e-09 |
| GCST90002383_352 | Hematocrit | 2.000000e-09 |
| GCST90002385_467 | High light scatter reticulocyte count | 6.000000e-14 |
| GCST90002386_537 | High light scatter reticulocyte percentage of red cells | 5.000000e-18 |
| GCST90002387_65 | Immature fraction of reticulocytes | 2.000000e-12 |
| GCST90002390_471 | Mean corpuscular hemoglobin | 5.000000e-16 |
| GCST90002391_1 | Mean corpuscular hemoglobin concentration | 1.000000e-18 |
| GCST90002395_363 | Mean platelet volume | 0.000000e+00 |
| GCST90002396_184 | Mean reticulocyte volume | 3.000000e-20 |
| GCST90002397_641 | Mean spheric corpuscular volume | 5.000000e-37 |
| GCST90002400_349 | Plateletcrit | 1.000000e-15 |
| GCST90002401_432 | Platelet distribution width | 8.000000e-38 |
| GCST90002402_295 | Platelet count | 9.000000e-74 |
| GCST90002403_127 | Red blood cell count | 6.000000e-14 |
| GCST90002406_73 | Reticulocyte fraction of red cells | 8.000000e-14 |
EFO canonical traits (9, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004309 | platelet count |
| EFO:0007984 | platelet component distribution width |
| EFO:0004527 | mean corpuscular hemoglobin |
| EFO:0004348 | hematocrit |
| EFO:0007986 | reticulocyte count |
| EFO:0004528 | mean corpuscular hemoglobin concentration |
| EFO:0010701 | mean reticulocyte volume |
| EFO:0007985 | platelet crit |
| EFO:0004305 | erythrocyte count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL3831223 (PROTEIN FAMILY)
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: enzyme — M1: Aminopeptidase N
CTD chemical–gene interactions
24 total (human), top 24 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | increases abundance, decreases expression, affects expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| beta-lapachone | increases expression | 1 |
| sodium arsenite | decreases expression, increases abundance | 1 |
| cobaltous chloride | decreases expression | 1 |
| nickel sulfate | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | decreases expression | 1 |
| MT19c compound | decreases expression | 1 |
| Arsenic | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Choline | affects expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Smoke | decreases expression | 1 |
| Dronabinol | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Aflatoxin B1 | decreases expression | 1 |
| Sodium Selenite | increases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 admet
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL4334276 | ADMET | Stability in pH 2 HCl assessed as aminopeptidase (unknown origin)-mediated compound hydrolysis by measuring parent compound remaining at 200 uM up to 6 hrs by RP-HPLC analysis | Astratides: Insulin-Modulating, Insecticidal, and Antifungal Cysteine-Rich Peptides from Astragalus membranaceus. — J Nat Prod |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.